Akorn, CSL sign distribution deal
BUFFALO GROVE -- Akorn Inc., a specialty pharmaceutical company, and CSL Biotherapies Inc., a subsidiary of CSL Ltd., have entered into an distribution agreement for Afluria, a seasonal influenza vaccine. Akorn will market and distribute two presentations of Afluria, which has pre-filled syringes without latex or thimerosal, and preserved multi-dose vials. Akorn will begin sales for the 2008 flu season.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.